The ISSCR’s VISION2030 gathers global leaders in stem cell research and regenerative medicine

Skokie, IL – The ISSCR’s VISION2030 is bringing together biotech CEOs who have successfully transformed scientific breakthroughs into thriving businesses that are improving human health. Join us for in-depth executive interviews that explore the next decade for the field on 7-8 January 2021. The event comes at a pivotal moment in regenerative medicine and stem…

Details

The Lustgarten Foundation and the AACR establish two new career development awards

The Lustgarten Foundation and the American Association for Cancer Research (AACR) have established two new career development awards for early-career female and underrepresented pancreatic cancer researchers, representing a generous commitment of the Lustgarten Foundation of up to $1.8 million. The awards will honor the extraordinary lives and legacies of United States Supreme Court Justice Ruth…

Details

MD Anderson and Xencor enter strategic collaboration to develop novel T cell-engaging bispecific antibodies for potential treatment of patients with cancer

HOUSTON and MONROVIA, Calif. ? The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic research collaboration and commercialization agreement to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer. This collaboration joins Xencor’s innovative XmAb® technology and protein engineering expertise to create bispecific antibodies…

Details

Dartmouth-Hitchcock and West Health bring geriatric telemedicine to rural New England

Lebanon, NH – Dartmouth-Hitchcock Health (D-HH), New Hampshire’s only academic health system serving nearly 2 million patients across northern New England, and West Health, a family of nonprofit and nonpartisan organizations working to lower health care costs to enable successful aging, are bringing accredited geriatric emergency care and, for the first time, providing older adults…

Details